Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsNeighborhood Health Plan RI multivitamin Prior Aut…
    Ask Trek AI about this page
    CurrentNeighborhood Health Plan of Rhode IslandPolicy N/A

    High-cost multivitamin prior authorization policy

    Customize your policy alerts

    Sign up for all Neighborhood Health Plan of Rhode Island policy alerts

    Know when Neighborhood Health Plan of Rhode Island releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines prior authorization requirements for multivitamin prescriptions above a $50 per-fill maximum cost edit for Neighborhood Health Plan of Rhode Island Medicaid FIDE SNP members. Affects pharmacy claims adjudication and prescribing providers.

    Policy Summary
    PayerNeighborhood Health Plan of Rhode Island
    PolicyHigh-cost multivitamin prior authorization policy
    Policy CodePolicy N/A
    Change TypeMaximum cost edit implemented
    Effective DateJan 1, 2026
    Last ReviewDec 1, 2025
    Next Review DateN/A
    Key ActionObtain prior authorization for multivitamin fills with a cost per fill above $50 by documenting trials of three formulary alternatives and submitting supporting clinical evidence.
    SourceLink
    POLICY UPDATE CHANGES

    A maximum cost edit was implemented for multivitamin preparations such that fills under $50 adjudicate without authorization while fills above $50 require prior authorization.

    $50max cost without auth
    $1.39

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    avg cost per fill
    >=5xthreshold vs avg
    12max coverage duration
    3required formulary failures

    Coverage Criteria

    Initial Authorization

    Covered when ALL of the following are met

    Initial authorization criteria

    • A. The requested drug/product is being used per the product's labeling or for an FDA-approved indication or a medically accepted indication as defined in AHFS-DI, Thomson Micromedex DrugDex, Clinical Pharmacology, Wolters Kluwer Lexi-Drugs, or peer-reviewed published medical literature.
    • B. The prescribed dose and quantity fall within the product's labeling or within FDA- or compendia-supported dosing guidelines.
    • C. The member has tried and failed at least 3 formulary alternative multivitamin preparations; documentation of the tried and failed alternatives must be submitted.
    • D. The prescriber has submitted clinical evidence (e.g., published comparative study results) showing that the requested high-cost multivitamin preparation is clinically superior to at least one of the tried and failed formulary alternatives.
    Initial therapy: See Initial Authorization criteria I.A–I.D: indication per labeling/compendia, appropriate dose/quantity, failure of >=3 formulary alternatives, and clinical evidence of superiority.

    Authorization up to 12 months if approved.

    Continuation of Therapy

    Covered when ALL of the following are met

    Continuation criteria: Patient meets all initial criteria in section I.

    Continuation approvals rely on persistence of initial approval criteria.

    Fills with a cost per fill of $50 or less are excluded from prior authorization and will adjudicate at point-of-sale without requiring prior approval. Any multivitamin fill with a reported cost per fill greater than $50 will reject at point-of-sale due to the maximum cost edit and will require submission of a prior authorization request.

    Initial Therapy

    Initial Therapy

    Initial authorization requirement for high-cost multivitamin fills (> $50 per fill)

    High-cost multivitamin initial therapy: Authorization requires meeting all Initial Authorization criteria I.A–I.D: use per labeling or a medically accepted indication, dose/quantity within labeling or compendia-supported dosing, documentation of trial and failure of ≥3 formulary alternative multivitamin preparations, and submission of clinical evidence demonstrating superiority over at least one tried alternative.

    Prior authorization is required for fills with cost per fill above the $50 maximum cost edit; approvals may be granted up to 12 months when criteria met.

    Continuation Therapy

    Continuation Therapy

    Continuation authorization requirement

    Continuation: Patient meets all initial criteria in section I.

    Continuation approvals valid up to the coverage duration.

    Provider Actions & Requirements

    Prior Authorization

    Prior Authorization Required

    Prior authorization is required for multivitamin prescriptions with a cost per fill above $50. Claims with a per‑fill cost greater than $50 will reject at point‑of‑sale under Neighborhood's maximum cost edit and will not adjudicate without an approved prior authorization.

    • Cost threshold: $50 per fill
    • Point‑of‑sale rejection triggers prior authorization requirement
    Step Therapy

    Required Failures of Formulary Alternatives

    Members must have tried and failed at least three formulary alternative multivitamin preparations before a high‑cost multivitamin authorization will be approved. The prescriber must document each trial and the reason for failure (for example: lack of efficacy, adverse reaction, intolerance, allergy, or nonresponse).

    • Minimum required failures: 3 formulary alternatives
    • Document reason for each failure (efficacy, adverse reaction, intolerance, allergy, nonresponse)

    Coding & Cost Edit

    Maximum cost edit per fill
    Maximum cost edit per fill$50 per fill — fills at or below this amount adjudicate at the pharmacy without prior authorization; fills above $50 will reject at point-of-sale and require prior authorization.
    Rationale for thresholdSet at least five times the 2024–2025 average multivitamin fill cost (average $1.39, excluding fills > $1,000) to prevent fraud, waste & abuse while preserving access to clinically necessary formulations.
    Effective applicationApplies to multivitamin preparations processed by Neighborhood's Pharmacy Department beginning in 2026.

    Step Therapy Requirements

    Step requirementRequired documentation
    Trial and failure of at least three formulary alternative multivitamin preparations
    Documentation of each tried and failed alternative (e.g., medication names, dates of trial, reason for failure) must be submitted
    Use per product labeling or FDA/medically accepted indication as defined by listed compendia
    Evidence that the requested product is used per labeling or a medically accepted indication (reference to AHFS‑DI, DrugDex, Clinical Pharmacology, Lexi‑Drugs, or peer‑reviewed literature)
    Prescribed dose and quantity within labeling or compendia‑supported dosing
    Prescription details confirming dose and quantity fall within product labeling or FDA/compendia dosing guidelines
    Clinical evidence of superiority over at least one tried alternative
    Attach clinical evidence (e.g., published comparative study results) demonstrating the requested high‑cost multivitamin is clinically superior to at least one tried and failed formulary alternative

    Definitions

    Medically accepted indication (definition)
    Definition source listMedically accepted indication as defined by any one of the following: AHFS-DI, Thomson Micromedex DrugDex, Clinical Pharmacology, Wolters Kluwer Lexi-Drugs, or peer-reviewed published medical literature.
    Usage requirementRequested product must be used per product labeling or for an FDA-approved or compendia-supported medically accepted indication.
    Evidence standardPeer-reviewed published medical literature must demonstrate sufficient evidence to support use when relied upon for a medically accepted indication.

    Background

    Neighborhood implemented a maximum cost edit on multivitamin preparations to reduce fraud, waste, and abuse (FWA) while preserving access to clinically necessary, higher-cost formulations. The cost threshold was set after utilization review of 2024–2025 claims data: the average multivitamin fill cost (excluding extreme outliers > $1,000) was approximately $1.39, and the threshold was chosen to be at least five times that average so that routine low-cost fills adjudicate without authorization but higher-cost fills undergo clinical review. Under this policy, fills above the $50 per fill limit will reject and require prior authorization to ensure appropriate medical necessity and documented justification.

    Revision History

    2026-01-01effective_dateLatest

    Policy effective date; a maximum cost edit of $50 per fill for multivitamin preparations implemented such that fills at or below $50 adjudicate without prior authorization while fills above $50 require prior authorization (material change).

    2026implementation_note

    Maximum cost edit operationalized for 2026 based on 2024–2025 utilization analysis to prevent fraud, waste, and abuse while allowing access to certain injectable formulations.

    Policy Summary
    PayerNeighborhood Health Plan of Rhode Island
    PolicyHigh-cost multivitamin prior authorization policy
    Policy CodePolicy N/A
    Change TypeMaximum cost edit implemented
    Effective DateJan 1, 2026
    Last ReviewDec 1, 2025
    Next Review DateN/A
    Key ActionObtain prior authorization for multivitamin fills with a cost per fill above $50 by documenting trials of three formulary alternatives and submitting supporting clinical evidence.
    SourceLink
    On This Page
    Coverage CriteriaInitial TherapyContinuation TherapyProvider Actions & RequirementsCoding & Cost EditStep Therapy RequirementsDefinitionsBackgroundRevision History
    Documentation Required

    Required Documentation for Authorization

    Submit the following documentation with the prior authorization request: indication for use, dose and quantity requested, date(s) and details of trials of each formulary alternative (including dose and duration), clinical rationale for why alternatives were inadequate, and supporting clinical records or literature. If claiming superiority of the requested product, include relevant published comparative studies or peer‑reviewed evidence.

    • Indication and dosing (must align with labeling or referenced compendia)
    • Details of 3+ formulary alternative trials: drug name, dose, dates, duration, and reason for failure
    • Clinical evidence demonstrating superiority (published studies or compendia references)
    • Relevant supporting clinical records (office notes, lab results)
    Billing Rule

    Cost Edit Rejection

    Neighborhood's pharmacy system enforces a maximum cost edit for multivitamins: fills with a per‑fill cost over $50 will reject at the pharmacy benefit point‑of‑sale. These claims will require submission and approval of a prior authorization before the claim will adjudicate.

    • Maximum cost edit: $50 per fill
    • Claims > $50 will reject at point‑of‑sale and require prior authorization